Biotechnology Assets Statistics

Total Valuation

BME:BST has a market cap or net worth of EUR 19.54 million. The enterprise value is 21.10 million.

Market Cap	19.54M
Enterprise Value	21.10M

Important Dates

The next estimated earnings date is Sunday, April 5, 2026.

Earnings Date	Apr 5, 2026
Ex-Dividend Date	n/a

Share Statistics

BME:BST has 70.03 million shares outstanding.

Current Share Class	70.03M
Shares Outstanding	70.03M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.10%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.40
PB Ratio	3.03
P/TBV Ratio	4.35
P/FCF Ratio	34.76
P/OCF Ratio	34.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.15
EV / Sales	6.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	37.54

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.34.

Current Ratio	1.02
Quick Ratio	1.02
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	3.88
Interest Coverage	-10.39

Financial Efficiency

Return on equity (ROE) is -30.40% and return on invested capital (ROIC) is -11.92%.

Return on Equity (ROE)	-30.40%
Return on Assets (ROA)	-7.67%
Return on Invested Capital (ROIC)	-11.92%
Return on Capital Employed (ROCE)	-16.88%
Revenue Per Employee	101,771
Profits Per Employee	-69,302
Employee Count	34
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-143,517
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.29% in the last 52 weeks. The beta is 2.24, so BME:BST's price volatility has been higher than the market average.

Beta (5Y)	2.24
52-Week Price Change	-14.29%
50-Day Moving Average	0.34
200-Day Moving Average	0.35
Relative Strength Index (RSI)	26.50
Average Volume (20 Days)	181,659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:BST had revenue of EUR 3.05 million and -2.08 million in losses.

Revenue	3.05M
Gross Profit	2.76M
Operating Income	-1.75M
Pretax Income	-2.22M
Net Income	-2.08M
EBITDA	-1.41M
EBIT	-1.75M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 615,487 in cash and 2.18 million in debt, giving a net cash position of -1.57 million or -0.02 per share.

Cash & Cash Equivalents	615,487
Total Debt	2.18M
Net Cash	-1.57M
Net Cash Per Share	-0.02
Equity (Book Value)	6.45M
Book Value Per Share	n/a
Working Capital	50,655

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 574,211 and capital expenditures -12,080, giving a free cash flow of 562,131.

Operating Cash Flow	574,211
Capital Expenditures	-12,080
Free Cash Flow	562,131
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 90.45%, with operating and profit margins of -57.27% and -68.10%.

Gross Margin	90.45%
Operating Margin	-57.27%
Pretax Margin	-72.80%
Profit Margin	-68.10%
EBITDA Margin	-46.20%
EBIT Margin	-57.27%
FCF Margin	18.41%

Dividends & Yields

BME:BST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.64%
FCF Yield	2.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:BST has an Altman Z-Score of -8.64 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.64
Piotroski F-Score	5